Updated USP Monograph 1092

Updated USP Monograph 1092 USP 711 (Dissolution) late 1960 USP 724 (Drug Release) 1985 USP 1088 (In Vitro and In Vivo Evaluation of Dosage Forms) 1995 USP 1092 (The Dissolution Procedure Development and Validation): Total Revision August 2015 USP 1094 CAPSULES DISSOLUTION TESTING AND RELATED QUALITY ATTRIBUTES USP 2040 Disintegration and Dissolution of Dietary Supplements EP Dissolution late 1960 EP Dissolution for Transdermal Systems late 1970 Harmonization in the year 2006 between USP, EP and JP Updated USP Monograph 1092 USP 1092 Performing Filter Compatibility Determining Solubility and Stability of Drug Substance in Various Media Choosing a Medium and Volume Choosing an Apparatus METHOD DEVELOPMENT Deaeration Sinkers Agitation Study Design Time Points Observations Sampling Cleaning Data Handling Dissolution Procedure Assessment ANALYTICAL FINISH Sample Processing Filters Centrifugation

Amlodipine Besylate/Valsa rtan Tablet II (Paddle) 75 Phosphate Buffer, pH 6.8 1000 5, 10, 15, 20, 30 and 45 07/21/2 011 Amoxicillin For Oral Suspension II (Paddle) 50 Water (degassed) 900 5, 10, 15, 20, 30 and 45 06/06/2 013 Amphetami ne ER Capsule II (Paddle) 50 750 ml of dilute HCl, pH 1.1 for the first 2

Loading..

Tags:

  Amlodipine, Besylate, Amlodipine besylate

Information